Opportunity ID: 362321
This opportunity is no longer listed as open or forecasted.
General Information
| Funding Opportunity Number | HT942526PRMRPCTA |
| Funding Opportunity Title | DoW Peer Reviewed Medical, Clinical Trial Award |
| Agency | Christopher L Baker Grants Officer |
| Document Type | synopsis |
| Version | 1 |
| Opportunity Category | Discretionary |
| Opportunity Category Explanation | Not specified |
| Funding Instrument Type | Cooperative Agreement; Grant |
| Category of Funding Activity | Science and Technology and other Research and Development |
| Category Explanation | Not specified |
| Expected Number of Awards | 9 |
| Cost Sharing or Matching Requirement | No |
| Posted Date | May 08, 2026 12:00:00 AM EDT |
| Last Updated Date | May 08, 2026 10:10:20 AM EDT |
| Original Closing Date | Sep 22, 2026 12:00:00 AM EDT |
| Original Closing Date Notes | Not specified |
| Current Closing Date | Sep 22, 2026 12:00:00 AM EDT |
| Current Closing Date Notes | Not specified |
| Estimated Synopsis Date | Not specified |
| Estimated Application Due Date | Not specified |
| Estimated Award Date | Not specified |
| Estimated Project Start Date | Not specified |
| Archive Date | Oct 22, 2026 12:00:00 AM EDT |
| Estimated Total Program Funding | 94,500,000 |
| Award Ceiling | none |
| Award Floor | none |
Assistance Listings
- 12.420 — Military Medical Research and Development
Eligibility
| Eligible Applicants | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
Description
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have significant impact on the treatment and management of a disease or condition addressed in one of the congressionally directed FY26 PRMRP topic areas and FY26 PRMRP strategic goals.
Distinctive Features: Must support a clinical trial. Supports two different application categories, based on the phase of planning for the clinical trial: Clinical Trial Only or Clinical Trial with Planning Phase. The Clinical Trial with Planning Phase option is intended to support the final phase of regulatory activities and planning activities that are necessary to be completed prior to initiation of the clinical trial. The planning phase cannot be used to finalize the intervention or support animal studies. Applications that already have regulatory approvals in place and are submitting to the Clinical Trial Only option may be prioritized over those requesting the Planning Phase option. Animal studies are not supported. Studies must complete all preclinical empirical laboratory work prior to the award start date.
Supports three funding levels, each offered with and without a Planning Phase:
Funding Level 1: Supports phase 0 or phase 1 clinical trials or non-phased trials with fewer than 100 participants.
Funding Level 2: Supports phase 2 clinical trials or non-phased trials with fewer than 300 participants.
Funding Level 3: Supports phase 3 clinical trials or non-phased trials with more than 300 participants.
Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $94.5M to fund approximately 9 Clinical Trial Award applications with total cost caps of $800,000 for the planning phase of a Clinical Trial with Planning Phase, $6M for Funding Level 1, $10M for Funding Level 2, and $20M for Funding Level 3 per award. The maximum period of performance is 4 years for the clinical trial, and 12 months for the planning phase. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
Additional Information
| Contact | Christopher L Baker Grants Officer |
| Contact Information | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| help@eBRAP.org | |
| Email Description | eBRAP Help Desk |
| Phone | 3016192332 |
Additional information
Version History
| Id | 362321 |
| Revision | 0 |
| Opportunity number | HT942526PRMRPCTA |
| Opportunity title | DoW Peer Reviewed Medical, Clinical Trial Award |
| Owning agency code | DOD-AMRAA |
| Opportunity category / Category | D |
| Opportunity category / Description | Discretionary |
| Synopsis / Opportunity id | 362321 |
| Synopsis / Version | 1 |
| Synopsis / Agency code | DOD-AMRAA |
| Synopsis / Agency name | Christopher L Baker Grants Officer |
| Synopsis / Agency phone | 3016192332 |
| Synopsis / Agency address desc | eBRAP Help Desk |
| Synopsis / Agency details / Code | AMRAA |
| Synopsis / Agency details / Seed | DOD-AMRAA |
| Synopsis / Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Synopsis / Agency details / Agency code | DOD-AMRAA |
| Synopsis / Agency details / Top agency code | DOD |
| Synopsis / Top agency details / Code | DOD |
| Synopsis / Top agency details / Seed | DOD |
| Synopsis / Top agency details / Agency name | Department of Defense |
| Synopsis / Top agency details / Agency code | DOD |
| Synopsis / Top agency details / Top agency code | DOD |
| Synopsis / Agency contact phone | 3016192332 |
| Synopsis / Agency contact name | Christopher L Baker Grants Officer |
| Synopsis / Agency contact desc | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Synopsis / Agency contact email | help@eBRAP.org |
| Synopsis / Agency contact email desc | eBRAP Help Desk |
| Synopsis / Synopsis desc | Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have significant impact on the treatment and management of a disease or condition addressed in one of the congressionally directed FY26 PRMRP topic areas and FY26 PRMRP strategic goals.
Distinctive Features: Must support a clinical trial. Supports two different application categories, based on the phase of planning for the clinical trial: Clinical Trial Only or Clinical Trial with Planning Phase. The Clinical Trial with Planning Phase option is intended to support the final phase of regulatory activities and planning activities that are necessary to be completed prior to initiation of the clinical trial. The planning phase cannot be used to finalize the intervention or support animal studies. Applications that already have regulatory approvals in place and are submitting to the Clinical Trial Only option may be prioritized over those requesting the Planning Phase option. Animal studies are not supported. Studies must complete all preclinical empirical laboratory work prior to the award start date. Supports three funding levels, each offered with and without a Planning Phase: Funding Level 1: Supports phase 0 or phase 1 clinical trials or non-phased trials with fewer than 100 participants. Funding Level 2: Supports phase 2 clinical trials or non-phased trials with fewer than 300 participants. Funding Level 3: Supports phase 3 clinical trials or non-phased trials with more than 300 participants. Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $94.5M to fund approximately 9 Clinical Trial Award applications with total cost caps of $800,000 for the planning phase of a Clinical Trial with Planning Phase, $6M for Funding Level 1, $10M for Funding Level 2, and $20M for Funding Level 3 per award. The maximum period of performance is 4 years for the clinical trial, and 12 months for the planning phase. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027. |
| Synopsis / Response date | Sep 22, 2026 12:00:00 AM EDT |
| Synopsis / Response date desc | Not specified |
| Synopsis / Posting date | May 08, 2026 12:00:00 AM EDT |
| Synopsis / Archive date | Oct 22, 2026 12:00:00 AM EDT |
| Synopsis / Cost sharing | No |
| Synopsis / Number of awards | 9 |
| Synopsis / Estimated funding | 94500000 |
| Synopsis / Estimated funding formatted | 94,500,000 |
| Synopsis / Award ceiling | none |
| Synopsis / Award floor | none |
| Synopsis / Applicant eligibility desc | Not specified |
| Synopsis / Create time stamp | May 14, 2026 01:50:30 PM EDT |
| Synopsis / Created date | May 08, 2026 10:10:20 AM EDT |
| Synopsis / Last updated date | May 08, 2026 10:10:20 AM EDT |
| Synopsis / Applicant types 1 / Id | 99 |
| Synopsis / Applicant types 1 / Description | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| Synopsis / Funding instruments 1 / Id | CA |
| Synopsis / Funding instruments 1 / Description | Cooperative Agreement |
| Synopsis / Funding instruments 2 / Id | G |
| Synopsis / Funding instruments 2 / Description | Grant |
| Synopsis / Funding activity categories 1 / Id | ST |
| Synopsis / Funding activity categories 1 / Description | Science and Technology and other Research and Development |
| Synopsis / Response date str | 2026-09-22-00-00-00 |
| Synopsis / Posting date str | 2026-05-08-00-00-00 |
| Synopsis / Archive date str | 2026-10-22-00-00-00 |
| Synopsis / Create time stamp str | 2026-05-14-13-50-30 |
| Agency details / Code | AMRAA |
| Agency details / Seed | DOD-AMRAA |
| Agency details / Agency name | Defense Health Agency Contracting Activity – DHACA |
| Agency details / Agency code | DOD-AMRAA |
| Agency details / Top agency code | DOD |
| Top agency details / Code | DOD |
| Top agency details / Seed | DOD |
| Top agency details / Agency name | Department of Defense |
| Top agency details / Agency code | DOD |
| Top agency details / Top agency code | DOD |
| Synopsis attachment folders 1 / Id | 79636 |
| Synopsis attachment folders 1 / Opportunity id | 362321 |
| Synopsis attachment folders 1 / Folder type | Full Announcement |
| Synopsis attachment folders 1 / Folder name | FY26 PRMRP CTA |
| Synopsis attachment folders 1 / Zip lob size | 945082 |
| Synopsis attachment folders 1 / Created date | May 08, 2026 10:11:07 AM EDT |
| Synopsis attachment folders 1 / Last updated date | May 14, 2026 01:50:30 PM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Id | 351884 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Opportunity id | 362321 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Mime type | application/pdf |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File name | HT942526PRMRPCTA_GG.pdf |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File description | FY26 PRMRP CTA Program Announcement |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File lob size | 1214882 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Created date | May 08, 2026 10:12:05 AM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Last updated date | May 14, 2026 01:50:30 PM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Synopsis att folder id | 79636 |
| Synopsis document urls | Not specified |
| Syn att change comments | Not specified |
| Cfdas 1 / Id | 433243 |
| Cfdas 1 / Opportunity id | 362321 |
| Cfdas 1 / Cfda number | 12.420 |
| Cfdas 1 / Program title | Military Medical Research and Development |
| Opportunity pkgs | Not specified |
| Closed opportunity pkgs 1 / Id | 292724 |
| Closed opportunity pkgs 1 / Topportunity id | 362321 |
| Closed opportunity pkgs 1 / Family id | 14 |
| Closed opportunity pkgs 1 / Dialect | XFDL2.2 |
| Closed opportunity pkgs 1 / Opportunity number | HT942526PRMRPCTA |
| Closed opportunity pkgs 1 / Opportunity title | DoW Peer Reviewed Medical, Clinical Trial Award |
| Closed opportunity pkgs 1 / Cfda number | 12.420 |
| Closed opportunity pkgs 1 / Opening date | May 08, 2026 12:00:00 AM EDT |
| Closed opportunity pkgs 1 / Closing date | Sep 22, 2026 12:00:00 AM EDT |
| Closed opportunity pkgs 1 / Owning agency code | DOD-AMRAA |
| Closed opportunity pkgs 1 / Program title | Military Medical Research and Development |
| Closed opportunity pkgs 1 / Contact info | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Closed opportunity pkgs 1 / Grace period | 0 |
| Closed opportunity pkgs 1 / Electronic required | Y |
| Closed opportunity pkgs 1 / Expected application count | 75 |
| Closed opportunity pkgs 1 / Expected application size | 1000000 |
| Closed opportunity pkgs 1 / Open to applicant type | 1 |
| Closed opportunity pkgs 1 / Is multi project | N |
| Closed opportunity pkgs 1 / Extension | |
| Closed opportunity pkgs 1 / Mimetype | application/pdf |
| Closed opportunity pkgs 1 / Last update | May 08, 2026 10:15:59 AM EDT |
| Closed opportunity pkgs 1 / Workspace compatible flag | Y |
| Closed opportunity pkgs 1 / Package id | PKG00292724 |
| Closed opportunity pkgs 1 / Opening date str | 2026-05-08-00-00-00 |
| Closed opportunity pkgs 1 / Closing date str | 2026-09-22-00-00-00 |
| Original due date | Sep 22, 2026 12:00:00 AM EDT |
| Original due date desc | Not specified |
| Synopsis modified fields | Not specified |
| Forecast modified fields | Not specified |
| Error messages | Not specified |
| Syn post date in past | Yes |
| Doc type | synopsis |
| Forecast hist count | 0 |
| Synopsis hist count | 0 |
| Assist compatible | No |
| Assist url | Not specified |
| Related opps | Not specified |
| Ost | CLOSED |
Related Documents
Packages
| Agency Contact Information: | eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00292724 | May 08, 2026 12:00:00 AM EDT | Sep 22, 2026 12:00:00 AM EDT | View |
